Skip to main content
Signal8

CORRIGAN MARK

SEC insider (Form 3/4/5 filer). CIK 0001250661. Director at Wave Life Sciences, Inc. (WVE). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in CAMBRIDGE, MA.

Companies CORRIGAN MARK has filed insider reports for

  • Wave Life Sciences, Inc. (WVE): Director
CORRIGAN MARK profile photo

CORRIGAN MARK

CIK: 0001250661

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Wave Life Sciences, Inc. logo
WVE

Wave Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Wave Life Sciences, Inc. logo
    WVE

    Wave Life Sciences, Inc.

    Oct 5, 2026
    Award
    Direct
    10.7K shares-
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Dec 8, 2025
    Sale
    Direct
    9.6K shares at avg. $13.09$126K
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Dec 8, 2025
    Sale
    Direct
    6.5K shares at avg. $14.06$92K
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Aug 11, 2025
    Award
    Direct
    12.7K shares-

1-4 of 4